Clinical trials

  • BUDESONIDE, GLYCOPYRRONIUM BROMIDE, FORMOTEROL FUMARATE DIHYDRATE for Chronic obstructive pulmonary disease
  • OLAPARIB for Triple negative breast cancer
  • apixaban for Intracerebral haemorrhage|Atrial fibrillation
  • PIVEKIMAB SUNIRINE for Acute myeloid leukemia (CD123-positive)
  • DERMATOPHAGOIDES FARINAE ALLERGOID, GLUTARALDEHYDE-MODIFIED; DERMATOPHAGOIDES PTERONYSSINUS ALLERGOID, GLUTARALDEHYDE-MODIFIED for Allergic rhinitis/rhinoconjunctivitis | Allergic asthma | House dust mite allergy
  • Alpelisib for Dent 2 disease|Dent's disease
  • Deuruxolitinib for Alopecia areata
  • PIVEKIMAB SUNIRINE for Acute myeloid leukemia | Other hematologic malignancies
  • ZIGAKIBART for IgA nephropathy
  • TUCATINIB for Metastatic colorectal cancer | HER2-positive colorectal cancer
  • NIVOLUMAB for Metastatic solid tumours
  • (3S,3'S,3A'S,10A'S)-6-CHLORO-3'-(3-CHLORO-2-FLUOROPHENYL)-1'-(CYCLOPROPYLMETHYL)-6'-METHYL-2-OXO-1,2,3',3A',10',10A'-HEXAHYDRO-1'H-SPIRO[INDOLE-3,2'-PYRROLO[2',3':4,5]PYRROLO[1,2-B]INDAZOLE]-7'-CARBOXYLIC ACID for Solid tumours